Genesis HealthCare posts $6.9M net loss for 2018

Zanesville, Ohio-based Genesis HealthCare System saw revenues increase in 2018 but ended the 12-month period with a net loss.

Advertisement

The integrated healthcare delivery system recorded consolidated operating revenue of $552.8 million in 2018, up 6.1 percent from $520.7 million in the same period a year prior, according to audited financial documents. Hospital net patient service revenue increased year over year, from $390.7 million to $411.8 million.  

At the same time, Genesis HealthCare’s total consolidated operating expenses increased 5.7 percent in 2018 to $549.7 million, while total hospital operating expenses increased by $16.3 million, or 4.6 percent. Increases in salaries and benefits, as well as supply costs, contributed to the growth. The system saw consolidated salaries and benefits increase by $10.4 million, or 4 percent, in 2018 compared to a year earlier. Consolidated supply costs increased by $4.8 million, or 6.4 percent, year over year.

For the 12 months ended Dec. 31, Genesis HealthCare recorded operating income of $3.1 million, compared to operating income of $705,000 in 2017.

After factoring in nonoperating results, including about $10 million lost on investments, the system ended 2018 with a $6.9 million net loss compared to net income of $17.7 million in the same period a year prior.

 

More articles on healthcare finance:

10 hospitals seeking RCM talent
Georgia Senate OKs surprise billing legislation: 6 things to know
5 recent RCM tips

 

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.